In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Rybelsus® (Semaglutide, Oral tablet) by Novo Nordisk has been FDA-approved since 2019 for Type 2 diabetes. Weight Method offers a separate option for Newark residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Newark is already seeing results
Rybelsus in Newark, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Newark from $199/month with virtual consultations and direct-to-door shipping.
For many people in Newark, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk, approved in 2019 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Newark.
Suburban life around Newark comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Semaglutide therapy addresses biology involved in weight regulation by reducing hunger signals, so Newark area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month, delivered to your door. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.